Skip to main content
Clinical Trials/JPRN-UMIN000026984
JPRN-UMIN000026984
Completed
未知

Investigation for the effect of anti-dyslipidemic drugs on serum level of trans-fatty acids - Trans-fat level-reducing drug study

Kobe University Graduate School of Medicine0 sites40 target enrollmentMarch 31, 2018
Conditionsdyslipidemia

Overview

Phase
未知
Intervention
Not specified
Conditions
dyslipidemia
Sponsor
Kobe University Graduate School of Medicine
Enrollment
40
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 31, 2018
End Date
May 31, 2017
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kobe University Graduate School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Lack of informed consent 2\. Pregnancy 3\. Allergy against ezetimibe or EPA

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
To study sugar lowering and cholesterol lowering effects of T. Saroglitazar in patients with abnormal Sugar and CholesterolHealth Condition 1: E116- Type 2 diabetes mellitus with other specified complications
CTRI/2022/10/046795maulana azad medical college
Recruiting
Not Applicable
A Clinical study in patients with dyslipidemia to determine the actual status of the percentage of patients achieving the target values for the management of LDL-Cholesterol specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition)
JPRN-UMIN000051501TOKYO CENTER CLINIC180
Completed
Not Applicable
A Clinical study in patients with dyslipidemia to determine the status of recognition and the percentage of patients achieving the target values for the management of each lipid parameter specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition), and to follow-up the achievement of the target values by subsequent treatment approaches.Dyslipidemia
JPRN-UMIN000046687Medical Corporation Chiseikai Tokyo Center Clinic350
Completed
Not Applicable
Clinical trials of the lipid improvement effect of Goishi tea evaluated by index LDL cholesterolHealthy individual
JPRN-UMIN000024028Kochi medical school hospital80
Unknown
Not Applicable
Clinical study on anti-atherosclerotic effect of azelnidipine/amlodipine in the hypertensive patients with type 2 diabetesHypertension
JPRN-UMIN000000495Advanced Medicine Study Group in Kyushu Island150